Guardant Health hits 52-week low after in-line guidance [Seeking Alpha]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Palo Alto, California-based Guardant ( GH ) recorded $155.1M in revenue for Q4 with ~22% YoY growth, exceeding its initial forecast of $153-$154M early this year as its precision oncology revenue climbed ~25% YoY to $142.2M. While its gross margin slipped to 60% from 63% in the prior year, its net loss rose ~34% YoY to $187M, mainly due to a one-time legal accrual charge of $83.4M. For 2023, the company reported $563.9M in revenue with ~25% YoY growth and said its 2024 revenue, excluding screening, could grow 16%–19% to $655M–$670M in line with $669.3M in FactSet consensus. After the results, Wall Street firms J.P. Morgan and Canaccord Genuity cut their price targets on GH while reiterating bullish views. More on Guardant Health Recommended For You Recommended For You About GH Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $45.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Guardant Health, Inc. (NASDAQ: GH) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $28.00 price target on the stock.MarketBeat
- Amplifier Security emerges from stealth to bridge divide between the workforce and security with AI copilot and human-in-the-loop automation [Yahoo! Finance]Yahoo! Finance
- Putting The Human Touch Back Into Cybersecurity With Amplifier [Forbes]Forbes
- FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/22/24 - Beat
GH
Sec Filings
- 5/2/24 - Form 4
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- GH's page on the SEC website